Medical Condition News

RSS

Cancer risk to increase following CT scans in younger patients, study reveals

Study leader, Professor John Mathews from the University of Melbourne said this small increase in cancer risk must be weighed against the undoubted benefits from CT scans in diagnosing and monitoring disease.

23 May 2013

Research finds number of links between dental health and overall health

If the eyes are the windows to your soul, then your mouth is the gateway to your overall health. Research has found a surprising number of links between the state of your dental health and your overall health.

23 May 2013

Innovative nebulizer to treat cystic fibrosis developed by Cambridge Consultants

Observing surfers with cystic fibrosis (CF) led scientists to discover that the inhaled mist of seawater has a therapeutic effect on the lung problems associated with the disease. Now the findings have been used by pharmaceutical company Parion Sciences and product development firm Cambridge Consultants in a revolutionary new aerosol delivery system. It enables CF sufferers to get the benefits of saltwater treatment in their own homes overnight while they sleep.

23 May 2013

Arthritis Research UK awards Cardiff researchers a grant to develop new drugs to treat osteoarthritis

Medical research charity Arthritis Research UK has awarded a team of researchers at Cardiff University a grant of £200,000 to investigate new drugs to treat early onset osteoarthritis. The team will investigate a new therapy to reduce the risk of developing osteoarthritis.

23 May 2013

Immune system attacks beneficial bacteria in several chronic human diseases

The human gut is loaded with commensal bacteria - "good" microbes that, among other functions, help the body digest food. The gastrointestinal tract contains literally trillions of such cells, and yet the immune system seemingly turns a blind eye. However, in several chronic human diseases such as inflammatory bowel disease, HIV/AIDS, cancer, cardiovascular disease, and diabetes, the immune system attacks these normally beneficial bacteria, resulting in chronic inflammation and contributing to disease progression.

23 May 2013

REPRISE II trial: Lotus Valve System meets primary endpoint in severe aortic valve disease patients

Boston Scientific Corporation reports positive results from a pre-specified analysis of the first 60 patients enrolled in the REPRISE II trial evaluating the performance and safety of the Lotus™ Valve System in symptomatic patients with severe aortic valve disease considered at high risk for surgical valve replacement.

23 May 2013

Mayo Clinic, Cancer Genetics form joint venture to improve cancer care

Mayo Clinic and Cancer Genetics Inc. today launched OncoSpire Genomics, a joint venture with the singular goal of improving cancer care by discovering and commercializing diagnostic tests that leverage next-generation sequencing.

23 May 2013

Merck releases statement on FDA's Advisory Committee meeting about suvorexant

Merck, known as MSD outside the United States and Canada, today provided the following statement after the conclusion of the Peripheral and Central Nervous System Drugs Advisory Committee meeting of the U.S. Food and Drug Administration about suvorexant, Merck's investigational medicine to treat insomnia.

23 May 2013

Cognoptix' SAPPHIRE II eye test identifies Alzheimer's disease patients via Ab signature in the eyes

Cognoptix, an emerging medical device company, announced today that its SAPPHIRE II eye test identified Alzheimer's disease patients via a beta amyloid ("Ab") signature in their eyes in a 10-subject proof-of-concept clinical trial.

23 May 2013

CardioKinetix reports meta-analysis study results of Parachute Ventricular Partitioning Device

CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced results of a meta-analysis study of the first-of-its-kind catheter-based Parachute Ventricular Partitioning Device. Six-month clinical results from 91 U.S. and European patients with ischemic heart failure were presented at the 2013 EuroPCR Conference in Paris by Dr. Martyn Thomas, M.D., chairman of Cardiology at St. Thomas Hospital in London, England.

23 May 2013

NIH-funded study raises hope for recovery of some adult patients with brain disorder

Scientists have reversed behavioral and brain abnormalities in adult mice that resemble some features of schizophrenia by restoring normal expression to a suspect gene that is over-expressed in humans with the illness.

23 May 2013

European, US NSTE-ACS guidelines recommend bivalirudin alone in patients undergoing PCI

Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment elevation acute coronary syndromes undergoing percutaneous coronary intervention.

23 May 2013

Cedars-Sinai Heart Institute honors Alain Carpentier with Corday Prize

Cedars-Sinai Heart Institute is honoring the physician widely known as the leading pioneer in modern mitral heart valve repair, Alain Carpentier, MD, PhD, with the second annual Eliot Corday, MD, International Prize in Heart Research.

23 May 2013

Health officials discuss new strategies to prevent rheumatic fever, rheumatic heart disease

Today, at the World Health Assembly, top health officials from New Zealand, South Africa, Australia, Fiji and Rwanda met to discuss the vital need for countries to integrate rheumatic fever and rheumatic heart disease prevention and control into national action plans.

23 May 2013

Johns Hopkins researchers find possible trigger of rheumatoid arthritis

In a series of lab experiments designed to unravel the workings of a key enzyme widely considered a possible trigger of rheumatoid arthritis, researchers at Johns Hopkins have found that in the most severe cases of the disease, the immune system makes a unique subset of antibodies that have a disease-promoting role.

23 May 2013

National Council urges consumers to select sunscreen products that offer broad spectrum protection

As millions of Americans prepare to enjoy the great outdoors this Memorial Day weekend, the National Council on Skin Cancer Prevention has designated the Friday before Memorial Day, May 24, 2013, as "Don't Fry Day" to raise awareness of the importance of practicing sun-safe behaviors.

23 May 2013

Study explains gender differences in the impact of OSA on cardiovascular disease, mortality

A new study from researchers in Japan indicates that obstructive sleep apnea is independently associated with visceral (abdominal) fat accumulation only in men, perhaps explaining gender differences in the impact of OSA on cardiovascular disease and mortality.

23 May 2013

University of Granada researchers patent new treatment for acne

University of Granada scientists have patented a new treatment for acne that is based on completely natural substances and is much more effective than artificial formulas because it does not create resistance to bacteria and has no secondary effects.

23 May 2013

Prosonix commences Phase 2 clinical study of PSX1002 for treatment of moderate to severe COPD

Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, has initiated a Phase 2 clinical study with PSX1002 that will assess its effect on lung function and the safety of a range of doses in patients with moderate to severe chronic obstructive pulmonary disease.

23 May 2013

$Upsher-Smith completes USL255 Phase III clinical trial in patients with refractory POS$

Upsher-Smith completes USL255 Phase III clinical trial in patients with refractory POS

Upsher-Smith Laboratories, Inc. today announced the successful completion of its global Phase III clinical trial for USL255 (extended-release topiramate), an internally developed program for the management of epilepsy in adults, using the company's proprietary formulation technology.

23 May 2013

Medical Condition News

Cancer risk to increase following CT scans in younger patients, study reveals

Research finds number of links between dental health and overall health

Innovative nebulizer to treat cystic fibrosis developed by Cambridge Consultants

Arthritis Research UK awards Cardiff researchers a grant to develop new drugs to treat osteoarthritis

Immune system attacks beneficial bacteria in several chronic human diseases

REPRISE II trial: Lotus Valve System meets primary endpoint in severe aortic valve disease patients

Mayo Clinic, Cancer Genetics form joint venture to improve cancer care

Merck releases statement on FDA's Advisory Committee meeting about suvorexant

Cognoptix' SAPPHIRE II eye test identifies Alzheimer's disease patients via Ab signature in the eyes

CardioKinetix reports meta-analysis study results of Parachute Ventricular Partitioning Device

NIH-funded study raises hope for recovery of some adult patients with brain disorder

European, US NSTE-ACS guidelines recommend bivalirudin alone in patients undergoing PCI

Cedars-Sinai Heart Institute honors Alain Carpentier with Corday Prize

Health officials discuss new strategies to prevent rheumatic fever, rheumatic heart disease

Johns Hopkins researchers find possible trigger of rheumatoid arthritis

National Council urges consumers to select sunscreen products that offer broad spectrum protection

Study explains gender differences in the impact of OSA on cardiovascular disease, mortality

University of Granada researchers patent new treatment for acne

Prosonix commences Phase 2 clinical study of PSX1002 for treatment of moderate to severe COPD

Upsher-Smith completes USL255 Phase III clinical trial in patients with refractory POS

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News